Browse the evidence

Reactive oxygen species (ROS) are not merely damaging byproducts but essential signaling molecules that regulate muscle regeneration, inflammation, and satellite cell activation.

Oxidative stress (ROS) is not just damage; it's a signal that tells your muscles to start repairing themselves. While too much is bad, some ROS is necessary for inflammation and regeneration. Don't try to eliminate all oxidative stress with supplements; let your body's natural antioxidant systems handle it.

Moderate alcohol consumption increases HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II, rather than by altering their fractional catabolic rate.

If you drink alcohol moderately, it may raise your HDL cholesterol levels by speeding up the production and transport of key proteins (apoA-I and apoA-II). This effect is dose-dependent, meaning more alcohol leads to a greater increase, up to a point. However, this does not necessarily mean heavy drinking is beneficial, as other health risks exist.

Fasting and metabolic states modulate olfactory sensitivity by upregulating metabolic hormone receptors (insulin, leptin, NPY) in the olfactory mucosa and bulb, enhancing odor detection during hunger.

If you feel your sense of smell is sharper when you are hungry, this is a normal biological response. Your body upregulates receptors for hormones like insulin and leptin in your nose to help you find food. This is not a flaw in your discipline; it is a designed feature of your metabolic system.

Gastric bypass surgery leads to sustained weight loss, partly mediated by a decrease in circulating ghrelin and an increase in peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) levels.

Gastric bypass surgery causes sustained weight loss, partly by altering gut hormones (lower ghrelin, higher PYY/GLP-1). This hormonal shift offers a model for developing non-surgical obesity treatments that replicate this profile.

Increasing long-chain omega-3 intake has little or no effect on the risk of developing type 2 diabetes or on glucose metabolism markers (HbA1c, fasting glucose, insulin, HOMA-IR).

If you are taking omega-3 supplements hoping to lower your blood sugar or prevent diabetes, this review suggests you are unlikely to see those specific benefits. The evidence shows no significant change in diabetes risk or glucose levels. Continue taking them if you like for general health, but do not rely on them for diabetes management.

Current cigarette smoking is associated with a metabolically adverse fat distribution profile characterized by higher central adiposity (waist circumference, waist-hip ratio) and lower peripheral adiposity (hip circumference) compared to never smokers, even after adjusting for BMI and lifestyle confounders.

If you smoke, do not rely on it for weight management. While you might weigh less than a non-smoker, your body stores fat in a more dangerous pattern around your waist rather than your hips. This increases your risk for metabolic issues regardless of your BMI. Quitting smoking is the best step for long-term health, even if it leads to some weight gain, as it helps normalize fat distribution over time.

The BclI polymorphism (G-allele) of the glucocorticoid receptor gene is associated with increased sensitivity to glucocorticoids, resulting in lower body mass index (BMI) and lean body mass in elderly populations.

If you are older and find it difficult to maintain muscle mass despite stable weight, your body may be genetically hypersensitive to cortisol. This sensitivity can lead to muscle loss (lower lean mass) rather than fat gain. Focus on resistance training to preserve lean mass, as your body may be more prone to catabolic effects from stress or endogenous cortisol.

Adipose tissue serves as a significant extra-gonadal source of estrogen through the conversion of androgens, meaning that body fatness directly influences the quantity and potency of circulating estrogen and thus reproductive ability.

Body fat is not just stored energy; it is an active endocrine organ that produces estrogen. Very low body fat levels can lead to estrogen deficiency, disrupting menstrual cycles and fertility.

Six weeks of CPAP therapy significantly reduces waking systolic and diastolic blood pressure and improves baroreceptor sensitivity in obese males with OSA, but does not alter insulin resistance, lipid profiles, or metabolic syndrome status within this timeframe.

If you are obese and have OSA, using CPAP nightly for at least 6 weeks will significantly lower your blood pressure and improve your heart's stress response. However, do not expect CPAP alone to fix your blood sugar, cholesterol, or weight in that short time; you must combine it with weight management strategies to address metabolic health.

Hepatic triglyceride content (IHCL) is significantly and positively correlated with central adiposity, specifically intra-abdominal and subcutaneous abdominal adipose tissue, independent of total body fat or BMI.

Your liver fat is closely tied to your abdominal fat, not just your total weight. Even if you are lean, high abdominal fat can lead to significant liver triglyceride accumulation. Conversely, losing abdominal fat is likely to reduce liver fat more effectively than focusing on total body weight alone. Non-invasive imaging like MRS can monitor this, but lifestyle changes targeting abdominal adiposity are the primary lever.

Obesity results from a failure of the central hypothalamic satiety mechanism (specifically the ventromedial nucleus) to inhibit the lateral feeding center, leading to hyperphagia, rather than from a simple failure of peripheral stomach sensations.

Focus on the quality and metabolic impact of food (specifically glucose utilization) rather than just volume or stomach sensations. The brain regulates intake based on how nutrients are processed, not just physical distension.

Short-term food intake regulation is driven by a 'glucostatic' mechanism where glucose utilization in the ventromedial hypothalamus triggers satiety, rather than blood glucose concentration alone.

Focus on how your body uses carbohydrates (glucose utilization) rather than just avoiding them. The brain's ability to process glucose signals satiety.

Transfeminine hormone therapy (estrogen + antiandrogens) induces feminizing physical changes including breast development, fat redistribution, and reduced body/facial hair, but does not significantly alter voice pitch.

Transfeminine hormone therapy will cause breast growth, fat redistribution to a female pattern, and reduced body/facial hair growth. It will NOT significantly lower your voice pitch. If voice pitch change is a priority, you will likely need voice training or surgery in addition to hormones. Breast development varies, with many reaching a plateau at a smaller cup size (AAA or less) within 6 months.

Testosterone supplementation in older men with low testosterone levels does not consistently improve muscle strength or functional ability, despite increasing lean body mass and decreasing fat mass.

If you are an older man with low testosterone, testosterone therapy may increase your lean body mass and decrease fat, but it is unlikely to make you stronger or improve your physical function. It does not replace the need for exercise, and the long-term safety and benefits for healthy older men remain unproven.

Brown adipose tissue (BAT) glucose uptake during cold exposure does not significantly contribute to systemic glucose clearance or thermogenesis because most taken-up glucose is metabolized into lactate or used for glyceroneogenesis rather than mitochondrial oxidation.

Cold exposure activates brown fat, but don't expect it to significantly lower your blood sugar or burn calories through glucose oxidation. The glucose taken up is mostly recycled into lactate or fat, not burned for heat. Focus on other mechanisms if targeting glucose metabolism.

Intracellular triglyceride (TG) lipolysis-derived fatty acids are the primary energy source for brown adipose tissue (BAT) thermogenesis upon cold activation, although circulating fatty acids can substitute if intracellular stores are unavailable.

Cold exposure triggers brown fat to burn stored fat inside the cells for heat. This is the main mechanism, though it can switch to blood fat if needed.

Weekly oral fecal microbiota transplantation (FMT) from lean donors does not significantly improve insulin sensitivity, body weight, or body composition in adults with obesity and mild-to-moderate insulin resistance over a 12-week period.

For adults with obesity and mild insulin resistance, receiving weekly oral FMT capsules from lean donors does not significantly improve insulin sensitivity, weight, or body composition over 12 weeks. While the treatment is safe and alters gut bacteria, it should not be expected to replace lifestyle interventions like diet and exercise for metabolic improvement.

FMT from lean donors successfully engrafts donor-specific bacteria in the majority of obese recipients, with effects persisting for at least 12 weeks, although the degree of engraftment varies significantly by donor.

FMT from lean donors can successfully introduce new bacteria into your gut, and these changes can last for months. However, this microbial change alone does not guarantee improvements in insulin sensitivity or weight loss.

Adding physiological measures such as heart rate to accelerometer data does not significantly improve the estimation of energy expenditure compared to using accelerometers alone.

If your goal is to track energy expenditure accurately, a standard accelerometer is likely sufficient. You do not need to invest in expensive multi-sensor devices that combine heart rate monitoring, as current evidence shows they do not significantly improve accuracy over accelerometers alone. Focus on consistent wear time rather than device complexity.

Positive Airway Pressure (PAP) therapy is the primary medical treatment for Obstructive Sleep Apnea (OSA) and significantly reduces daytime sleepiness and apnea-hypopnea index (AHI), though its impact on cardiovascular mortality and hard endpoints remains less definitive.

If you have OSA, PAP therapy is the most effective way to keep your airway open and reduce sleepiness. You need to find the right pressure and mask type, which may take some trial and error, but sticking with it is crucial for your long-term health and quality of life.

Surgical interventions and oral appliances are alternative treatments for OSA, with efficacy varying by patient anatomy and severity, often serving as options when PAP is not tolerated.

If PAP doesn't work for you, talk to your doctor about surgical options or oral appliances. These can be effective for some people, especially if your anatomy is suitable, but they require careful evaluation.

Elevated circulating levels of branched-chain amino acids (Leu, Ile, Val) and aromatic amino acids (Phe, Tyr) are strongly associated with insulin resistance (HOMA-IR) in young, normoglycemic adults, with associations being significantly stronger in men and in women only when abdominally obese.

If you are young and healthy, high levels of certain amino acids in your blood may signal early insulin resistance, especially if you carry weight around your midsection. This is not a diagnosis of diabetes, but a signal to prioritize physical activity and metabolic health. The study suggests these markers are secondary to insulin resistance rather than the cause, so focusing on overall metabolic health (exercise, healthy fats) is more effective than restricting protein intake.

Genetic variants that regulate circulating amino acid and lipid levels generally do not cause insulin resistance, suggesting that elevated amino acids are likely secondary markers of insulin resistance rather than causal drivers.

Genetic evidence suggests that high amino acid levels in your blood are likely a symptom of insulin resistance, not the cause. This means you don't need to restrict protein intake to fix insulin resistance. Instead, focus on lifestyle factors like exercise and healthy fats that improve how your body uses insulin.

Mendelian randomization using semiparametric methods (fractional polynomial or piecewise linear) reveals that the causal relationship between BMI and systolic blood pressure is nonlinear, showing a steep increase up to a BMI of ~32 kg/m2 and a flatter or slightly negative slope thereafter, while the relationship with diastolic blood pressure increases almost linearly up to ~40 kg/m2.

For individuals with a BMI between 25 and 32, blood pressure tends to rise sharply with each unit of BMI. However, once BMI exceeds 32, the rate of blood pressure increase may slow down or even slightly decrease, suggesting a complex biological interaction rather than a simple linear progression. For Diastolic Blood Pressure, the increase remains relatively linear up to a BMI of 40. This implies that weight management strategies might have different impacts on blood pressure depending on the starting BMI and the type of blood pressure being monitored.